AAN: New AAN/AES Guidelines on Treating First Seizure

This article originally appeared here.
Share this content:
AAN: New AAN/AES Guidelines on Treating First Seizure
AAN: New AAN/AES Guidelines on Treating First Seizure

(HealthDay News) -- One in 10 people worldwide will have a seizure in their lifetime, experts say. Now, two medical groups have issued a new guideline on how to treat them. The guideline, published in the April 21 issue of Neurology, will be presented this week at the annual meeting of the American Academy of Neurology, held from April 18 to 25 in Washington, D.C.

The decision to treat a patient after a first seizure is complex because physicians must weigh the risks and benefits on an individual basis, according to the American Academy of Neurology and the American Epilepsy Society. After a review of all available evidence, the two organizations concluded that administering an antiepileptic drug immediately after a first unprovoked seizure may reduce the risk of more seizures.

"This is a valuable new guideline that could change the approach many doctors take to treating a first seizure and could improve patients' lives," guideline coauthor Allan Krumholz, M.D., of the University of Maryland School of Medicine in Baltimore, said in an academy news release. "About 150,000 adults have an unprovoked first seizure in the United States each year. Even one seizure is traumatic and affects a person's life in many social ways, such as driving a car, employment options, falling risks, and the fear of having another seizure in public. This guideline clarifies when risk factors put individuals at greater risk," Krumholz said.

Adults who have an unprovoked first seizure are at greatest risk for another seizure within two years. The risk varies from 21 to 45 percent, according to the guideline. In addition, there was strong evidence that the risk of a second seizure is highest in people with a previous brain insult -- such as stroke, brain tumor, or head injury -- and in those with an electroencephalogram test result that shows signs of epilepsy.

Abstract
Full Text
More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Panel Has Tie Vote on New Type 1 Diabetes Drug

FDA Panel Has Tie Vote on New Type ...

Zynquista is a once-daily pill meant to help type 1 diabetes patients manage their blood glucose levels

FDA Investigating Paclitaxel-Coated Balloons, Paclitaxel-Eluting Stents

FDA Investigating Paclitaxel-Coated Balloons, Paclitaxel-Eluting Stents

Investigation triggered by meta-analysis showing possible increased mortality in PAD patients at 2 years

Frailty Could Increase Susceptibility for Dementia

Frailty Could Increase Susceptibility for Dementia

Authors say frailty should be considered in clinical care, management of Alzheimer dementia

is free, fast, and customized just for you!




Already a member?

Sign In Now »